Vor Biopharma (VOR) Earnings Date & Reports

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

VOR is expected to report earnings to fall 34.87% to -75 cents per share on November 11

Vor Biopharma VOR Stock Earnings Reports

Q3'26

Est.

$-0.76

Q2'26

Missed

by $0.43

Q1'26

Missed

by $5.01

Q4'25

Beat

by $84.98

Q3'25

Missed

by $121.50

The last earnings report on August 12 showed earnings per share of -115 cents, missing the estimate of -73 cents. With 504.57K shares outstanding, the current market capitalization sits at 1.32B.

View a ticker or compare two or three

VOR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days